Utah Physician Ebook Continuing Education

__________________ Effective Management of Acute and Chronic Pain with Opioid Analgesics, 2nd Edition

b. report the incident to the local law enforcement agency.

4a. If a practitioner fails to document the practitioner’s intentions relative to refills of controlled substances in Schedules III through V on a prescription form, it shall mean no refills are authorized. b. A refill is not permitted on a prescription for a Schedule II controlled substance. 5. Refills of controlled substance prescriptions shall be permitted for the following periods from the original date of the prescription: a. Schedules III and IV, for six months from the original date of the prescription; and b. Schedule V, for one year from the original date of the prescription. 6. A refill may not be dispensed until sufficient time has passed since the date of the last dispensing that 80% of the medication in the previous dispensing should have been consumed if taken according to the prescribing practitioner’s instruction. 7. A controlled substance prescription may not be issued or dispensed without specific instructions from the prescribing practitioner on how and when the drug is to be used. 8. Refills after expiration of the original prescription term shall require issuance of a new prescription by the prescribing practitioner. 9. Each prescription for a controlled substance and the number of refills authorized shall be documented in the patient records by the prescribing practitioner. 10. A practitioner may prescribe, dispense, or administer a Schedule II controlled stimulant when indicated if, before initiating treatment using the Schedule II controlled stimulant, the practitioner: a. obtains an appropriate history and physical examination; b. rules out the existence of recognized contraindications; and c. has no reason to believe that the patient has consumed or disposed of any controlled stimulant other than in compliance with the treating practitioner’s directions. R156-37-604. Prescribing of Controlled Substances for Weight Reduction or Control. 1. A practitioner may not prescribe, dispense, or administer a Schedule II or Schedule III controlled substance for weight reduction or control. 2. A prescribing practitioner may prescribe or administer a Schedule IV controlled substance in treating excessive weight leading to increased health risks only if the prescribing practitioner complies with each of the following conditions:

3. Each record required by federal and state laws or rules shall be maintained by the licensee for five years. If a licensee sells or transfers ownership of records in any way, those records shall be maintained separately from other records of the new owner. 4. Prescription records may be maintained electronically if: a. the original of each prescription, including

telephone prescriptions, is maintained in a physical file and contains the information required by federal and state law; and b. an automated data processing system is used for the storage and immediate retrieval of refill information for prescription orders for controlled substances in Schedule III and IV, in accordance with federal guidelines.

5. Each record relating to Schedule II controlled substances received, purchased, administered, or dispensed by the practitioner shall be maintained separately from other records of the pharmacy or practice. 6. Each record relating to Schedules III, IV, and V controlled substances received, purchased, administered, or dispensed by the practitioner shall be maintained separately from other records of the pharmacy or practice. R156-37-603. Restrictions Upon the Prescription, Dispensing, and Administration of Controlled Substances. 1. A practitioner may prescribe or administer the Schedule II controlled substance cocaine hydrochloride only as: a. a topical anesthetic for mucous membranes in surgical situations in which it is indicated; and b. as local anesthetic for the repair of facial and pediatric lacerations, if the controlled substance is mixed and dispensed by a licensed pharmacist in the proper formulation and dosage. 2. A practitioner may not prescribe or administer a controlled substance without taking into account the

drug’s potential for abuse, and the possibility: a. that the drug may lead to dependence; b. that patient may get the drug for a nontherapeutic use or to distribute to others; and c. that an illicit market exists for the drug.

3. Under Subsection 58-37-6(7)(f)(vii), unless the prescribing practitioner determines there is a valid medical reason to allow an earlier dispensing date, the dispensing date of a second or third prescription shall be at least 30 days from the dispensing date of the previous prescription, to allow for receipt of the subsequent prescription before the previous prescription runs out.

33

MDUT1125

Powered by